Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Studsvik's US subsidiary, Studsvik Scandpower Inc, exposed to fraud - incorrect payments

Studsvik's US subsidiary Studsvik Scandpower Inc, within the Scandpower business area, has been exposed to an advanced financial fraud which has resulted in incorrect payments of USD 1.3 million which will have a negative impact on the Scandpower business area's earnings for the third quarter of 2024. The investigation is ongoing internally and the incident has been reported to the relevant US authorities and insurance companies. Studsvik has immediately started work to further strengthen the internal control systems to prevent similar events from occurring. For further information

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BWXC7Y93 Issuer Name Fidelity Special Values PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Brewin Dolphin Limited City of registered office (if applicable) Newcastle upon Tyne Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the

EQT sets target fund size for EQT Private Capital Asia’s BPEA IX at USD 12.5 billion

THIS IS INFORMATION THAT EQT AB (PUBL) IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SUBMITTED FOR PUBLICATION, THROUGH THE AGENCY OF THE CONTACT PERSON SET OUT BELOW AT 18:00 CEST ON 14 AUGUST 2024. EQT has today set the target size for EQT Private Capital Asia’s BPEA Private Equity Fund IX (the “Fund” or “BPEA IX”) at USD 12.5 billion. The actual fund size is dependent on the outcome of the fundraising process and may be higher or lower than the target size; the hard cap of the fund will be set at a later date. BPEA IX’s investment strategy

UIE's share buy-back programme

As stated in UIE’s Half Year Report 2024, UIE has resolved to initiate a new buy-back programme with the intention of acquiring up to 3% of its share capital before the end of December 2025, so long as the shares continue to be traded at a material holding discount. The share buy-back programme is initiated pursuant to the authorisation granted at the Annual General Meeting in May 2022. UIE has decided that the share buy-back will be carried out in two parallel programmes.  Safe Harbour programmeUIE initiates a share buy-back programme that will be conducted under the European

UIE's Half Year Report 2024

On Wednesday, 14 August 2024, UIE Plc. announced its financial results for the first half of 2024.  Highlights from H1 2024: UIE achieved a satisfactory net result for the first six months of 2024 despite the global economic challenges posed by the highest Federal fund rates since 2001 and escalating geopolitical tensions, notably in the Middle East. This result was mainly a function of the improved production and higher average selling prices for CPO and PK, as well as lower production costs in UP. UP · UP reported a record net profit of MYR 320.7 million, reflecting an

Relais Group Plc: Share Repurchase 14.8.2024

Relais Group Plc  ANNOUNCEMENT  14.8.2024 Relais Group Plc: Share Repurchase 14.8.2024 In the Helsinki Stock Exchange Trade date           14.8.2024Bourse trade         BuyShare                  RELAISAmount             470 SharesAverage price/ share    13,5500 EURTotal cost            6 368,50 EUR Relais Group Plc now holds a total of 43 699 sharesincluding the shares repurchased on 14.8.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne

#24-282 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

SOFTSWISS Poised to Become First Certified Software Provider in Brazil

SOFTSWISS, a global leader in the iGaming technology with over 15 years of experience, is on track to secure certification for its Casino Platform and Sportsbook in Brazil. The certification process, conducted by an authorised testing laboratory, is currently underway. As the process unfolds, SOFTSWISS shares insights into the critical requirements for success in the burgeoning Brazilian market.Last year, SOFTSWISS obtained GLI-19 and GLI-33 certifications ,

Genexis celebrates successful first year of North American expansion at FiberConnect 2024

Genexis, a leading provider of cutting-edge fiber-to-the-home (FTTH) and broadband solutions for the in-home network experience, is excited to announce its participation in FiberConnect 2024.Genexis’ attendance marks its first year in the North American market, with significant milestones, including four strategic partnerships, establishing a company entity, and achieving FCC certification. Delivery of first direct project Genexis' official North American market launch was at FiberConnect 2023. Since then, the company has won and delivered its first direct project, Williamstown,

Borr Drilling Limited – 2024 AGM Results Notification

Borr Drilling Limited (the “Company”) advises that the 2024 Annual General Meeting of the Company was held on August 14, 2024 at 10:00 ADT at 2[nd] Floor, The S.E. Pearman Building, 9 Par-la-Ville Road, Hamilton HM 11, Bermuda.  The audited consolidated financial statements for the Company for the year ended December 31, 2023 were presented to the Meeting. The following resolutions were passed: 1. To set the maximum number of Directors of the Company to be not more than seven. 2. To re-elect Tor Olav Trøim as a Director of the Company. 3. To re-elect Alexandra Kate Blankenship as

Medical simulation company moves HQ to Gothenburg

Norwegian technology startup Skillup is relocating its operations to Gothenburg. The region’s capabilities within medical simulation, its strong startup infrastructure and the ability to attract international investments were a few of the reasons behind the move.The company, which is registered in Sweden as Simlogic AB, specialises in the use of virtual reality (VR) and gaming technology for medical simulation. “There is a lack of sufficient practice time for clinicians to develop and practice emergency medical competencies and clinical decision-making skills. While conventional

Read original

Genexis partners with Titan Telecom International to expand North American market

Genexis, a leading provider of cutting-edge fiber-to-the-home (FTTH) and broadband solutions for the home, is thrilled to announce a new partnership with Titan Telecom International, a U.S. supplier of premium networking equipment.This collaboration marks the expansion of Genexis' footprint in North America, aiming to bring advanced and sustainable broadband solutions to everyone’s home. "Partnering with Titan Telecom International is a crucial step in our North American expansion strategy. Titan's dedication to quality and exceptional service aligns perfectly with us, and together, we

Dicot Pharma AB publishes prospectus in connection with the upcoming rights issue

Uppsala, Sweden, August 14, 2024. The Board of Directors of Dicot Pharma AB today publishes an EU growth prospectus (the "Prospectus") in relation to the rights issue of units consisting of shares and warrants of series TO6 resolved by the Board of Directors on August 7, 2024 (the "Rights Issue"). The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH

Find the Best Low Deposit Casinos with CasinoRank's Expert Reviews

Explore $1, $2, $3, $5, and $10 Deposit Casinos with Exclusive Bonuses and In-Depth Reviews CasinoRank, a leading authority in the online gambling industry, is thrilled to announce the launch of its expert guides on low minimum deposit casinos. These guides help players discover the best online, live, and mobile casinos that accept deposits as low as $1, $2, $3, $5, and $10, complete with detailed reviews and exclusive bonusesAffordable Gaming Options for Every Player The new series addresses the increasing demand for affordable gaming options, providing players with valuable

MAGic™ BioProcessing Announces Changes to Board of Directors

Uppsala, Sweden - August 14, 2024 – MAGic BioProcessing is pleased to announce the appointment of Günter Jagschies new board member while also acknowledging the departure of our valued board member Kristina Köhler. These changes mark an important step in the company's ongoing commitment to excellence and strategic growth. Dr. Jagschies brings a wealth of experience and expertise in the bioprocessing field, having held key positions at GE Healthcare Life Sciences, now known as Cytiva. His extensive background and knowledge will be invaluable as MAGic Bioprocessing continues to drive

International gaming company extends and expands its collaboration with Aixia for backup solution to a value of SEK 1 million

Mölndal                                                                                      2024-08-14 Aixia announces that a major international gaming company has extended and expanded its partnership with us. The new business, which is worth SEK 1 million, involves an upgrade of their existing backup solution. The expansion is proof of the trust and satisfaction the customer feels for Aixia's services. Our long-term collaboration has developed into a partnership where we continuously contribute to ensuring the customer's data protection and business continuity. By choosing to

Interim Report April–June 2024: Improved quarterly results but with continued challenges

For the first half of the year LKAB’s net sales and operating profit both decreased as a consequence of missed deliveries at the beginning of the year. In terms of the second quarter, however, operating profit increased to MSEK 2,666 (2,257) as parts of accumulated inventories were delivered.Net sales for the second quarter amounted to MSEK 9,851 (9,350). The increase is mainly due to higher deliveries and a somewhat weaker Swedish krona. Operating profit amounted to MSEK 2,666 (2,257) and was also affected by insurance payouts received during the quarter as compensation for missed

Invitation to presentation of second quarter and half year result 2024

Multiconsult (OSE: MULTI) second and half year results 2024 will be released on Wednesday 21 August at 07:00 CET. Multiconsult hereby invites you to the presentation of the results and participants are invited to attend.The Norwegian presentation will be held at Hotel Continental, Stortingsgata 24/26, Oslo, at 08:30. The presentations will be held by Grethe Bergly (CEO) and Ove B. Haupberg (CFO). The results will also be presented through live webcasts: In Norwegian at 08:30 and in English at 09:30. Participants will have the opportunity to submit questions online throughout the webcast

PhII preliminary results from skin cancer clinical trial show an 86%overall reduction of tumor size, complete clearance in 51%of the patients and the potential to be utilized as a first-line therapy

Oslo, 14 August 2024. Lytix Biopharma (“Lytix”) announces that its Nasdaq-listed licensing partner Verrica Pharmaceuticals reports positive top-line Phase II results from its study in patients with basal cell carcinoma (BCC) - the largest skin cancer disease globally with a projected global market size of USD 11.5 bn in 2028 (CAGR 7.9%) and 3.6 million new cases in the US annually [1].    The study investigates Lytix’s lead drug candidate LTX-315 in BCC patients and shows impressively an: · 86 percent overall reduction of tumor size · 51 percent complete clearance rate of

Implantica presents the second quarter 2024 on August 21 at 15:00 CEST

Implantica AG (publ) invites investors to a presentation of the second quarter 2024 at 15:00 CEST on August 21. The interim report for the second quarter will be published at 8:00 a.m. CEST on the same day.The presentation will be in English via an audiocast with teleconference: If you wish to participate via webcast, please use the following link: · https://ir.financialhearings.com/implantica-q2-report-2024 If you wish to participate via teleconference, please register on the link below. After registration, you will be provided the phone number and a conference ID to access the

Axentia Group AB (publ) appoints new CFO

Axentia Group AB (publ) ("Axentia" or the "Company") appoints Johanna Klint as new Chief Financial Officer (CFO) as of September 1, 2024. Johanna Klint will also take on the role of CFO of the parent company Axentia Group Holding AB. As part of the Company's continued expansion, the management team will be strengthened through the appointment of a new CFO with broad experience from both private and listed companies. Johanna Klint comes from a previous position as CFO and Group Management Member at Vectura Fastigheter AB. Johanna also has extensive experience as an Investment Manager at

There are no items matching the current filter
There are no more items matching the current filter
Back to top